THE INDUSTRY FACES
New Key Account Manager at Leiber GmbH
D Dr Thomas Bissot
r Thomas Bissot has joined Leiber GmbH in their Animal Nutrition business unit as the Global Key Account Manager for Pet Food.
In this newly created position, he is taking care of the international market leaders and opinion formers in the pet food industry in order to expedite the expansion of Leiber yeast products and extracts in the pet food segment around the world. Dr Bissot is concentrating not only on supporting existing customers, but also on acquiring new business partners by developing customer-specific sales and marketing campaign solutions. Following a degree in veterinary medicine at the University of Liège in Belgium, Dr Bissot first gained practical experience in a small-animal clinic and at the Faculty of Veterinary Medicine in Ghent. In 2005 he joined the Royal Canin Research and Development Centre as project manager. His projects here focussed on small animal gastroenterology and obesity biology, as well as the nutrition and behaviour of small animals in intensive-care medicine.
From 2008 to 2015 he was responsible for scientific communication and coordination between 60 countries in the eastern and southern region. From 2016 to 2017, he also achieved an executive MBA at Montpellier Business School.
Joining the board with immediate effect
ngve Myhre has been announced by Benchmark today as a Non-Executive Director of the Company with immediate effect.
At 48 Mr Myhre has more than 20 years experience in the aquaculture sector as a senior executive, adviser and investor. He was chief executive of leading Norwegian salmon producer Salmar, and of international white fish supplier Aker Seafood during periods of successful growth. He is now chairman of Chilean salmon producer Nova Austral, and sits on the boards of Mediterranean fish producer Andromeda and Norwegian aquaculture research institute Nofima. He also acts as strategic adviser to investors in the aquaculture sector. He has a very strong track record in Benchmark’s focus area of aquaculture, both in the Norwegian and international markets.
Alex Hambro, Benchmark’s Chairman, commented, “The Board of Benchmark carried out an extensive international search to bring to the Board additional international industry and commercialisation expertise. Attracting Yngve is a testament of the strength of our industry standing, our technology platform and our potential.”
Bringing over three decades of experience
ugo Wahnish has been announced by Benchmark today as a Non-Executive Director of the Company with immediate effect.
At 65 he has over 35 years of experience in the animal health and pharmaceuticals industry, firstly with GlaxoSmithKline, and more recently with Merck during a period of major growth in the organisation.
He previously held the post of Chief Commercial Officer Animal Health at Merck, having responsibility for Merck’s commercial operations worldwide.
Since stepping down from that role in 2012, Mr Wahnish has acted as an independent senior advisor with several multinational companies, private equity groups and consulting firms primarily in the animal health sector. He brings a wealth of international experience to the board of Benchmark, alongside his expertise in aggressively growing businesses and in the commercialisation of medicines and animal health products. Alex Hambro, Benchmark’s Chairman, commented, “The Board of Benchmark carried out an extensive international search to bring to the Board additional international industry and commercialisation expertise. Attracting Hugo is a testament of the strength of our industry standing, our technology platform and our potential.”
56 | November 2017 - International Aquafeed